Neil K Kamdar, MD
Pain Management · Emeryville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Offices
- 6
- Since medical school
- 15 years
- Rush Medical College of Rush University, 2011
Offices
6 locations · Pain and Rehabilitative Consultants Medical Group · 7 clinicians in this group
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kamdar’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A144608 · Current
Licensed to practise in California · since 2016 · expires 2027-10-31 · Rush Medical College of Rush University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Anesthesiology - Anesthesiology
- American Board of Anesthesiology - Pain Medicine
Original Medicare doctor bills
$30,903
Medicare paid this office $30,903 for 63 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 56 | $24,464 | $83 |
| Return visit (30+ min) | 18 | $3,137 | $108 |
| Short return visit | 12 | $1,286 | $54 |
| Testing for presence of drug, read by direct observation | 44 | $889 | $12 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 15 | $257 | $13 |
Who their Medicare patients are
63 Original Medicare patients in 2024. Average age 70 · Women 57% · Also on Medicaid 60% · Health risk score 1.75. Above the middle of the specialty; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 75% · Diabetes 33% · Depression 29% · Chronic kidney disease 25% · COPD 22% · Coronary heart disease 19%.
The office billed $162,829, Medicare allowed $40,171 and paid $30,903; for 526 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 63 | 526 | 70 | 1.75 | $162,829 | $30,903 |
| 2023 | 74 | 559 | 69 | 1.54 | $215,461 | $38,191 |
| 2022 | 90 | 795 | 66 | 1.64 | $298,200 | $50,324 |
| 2021 | 83 | 988 | 66 | 1.45 | $298,326 | $63,136 |
| 2020 | 99 | 1,192 | 66 | 1.58 | $319,143 | $57,690 |
| 2019 | 102 | 1,140 | 65 | 1.77 | $318,977 | $59,141 |
| 2018 | 84 | 779 | 64 | 1.89 | $196,545 | $37,685 |
| 2017 | 35 | 169 | 64 | 1.49 | $45,148 | $11,892 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Short return visit (20+ min) | 62 | $31,179 | $78 |
| Return visit (30+ min) | 14 | $2,358 | $112 |
| New patient visit (45+ min) | 13 | $1,966 | $151 |
| Testing for presence of drug, read by direct observation | 61 | $1,136 | $12 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 19 | $323 | $12 |
2022: 4 services
| Short return visit (20+ min) | 73 | $38,009 | $78 |
| New patient visit (45+ min) | 25 | $3,480 | $139 |
| Return visit (30+ min) | 17 | $3,244 | $105 |
| Testing for presence of drug, read by direct observation | 68 | $1,307 | $12 |
2021: 6 services
| Short return visit (20+ min) | 70 | $32,840 | $83 |
| Telephone medical discussion with physician, 21-30 minutes | 41 | $16,485 | $120 |
| Return visit (30+ min) | 23 | $3,777 | $114 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $2,882 | $66 |
| Testing for presence of drug, read by direct observation | 67 | $1,386 | $13 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 19 | $267 | $13 |
2020: 7 services
| Short return visit (20+ min) | 82 | $30,689 | $62 |
| Telephone medical discussion with physician, 11-20 minutes | 37 | $9,647 | $71 |
| New patient visit (45+ min) | 33 | $4,891 | $148 |
| Return visit (30+ min) | 38 | $4,210 | $86 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $2,062 | $103 |
| Testing for presence of drug, read by direct observation | 73 | $1,352 | $13 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 14 | $212 | $12 |
2019: 4 services
| Short return visit (20+ min) | 84 | $35,401 | $65 |
| Return visit (30+ min) | 54 | $9,624 | $99 |
| New patient visit (45+ min) | 50 | $6,875 | $138 |
| Testing for presence of drug, read by direct observation | 91 | $1,853 | $12 |
2018: 6 services
| Short return visit (20+ min) | 59 | $19,893 | $65 |
| New patient visit (45+ min) | 38 | $5,612 | $148 |
| Return visit (30+ min) | 24 | $3,384 | $100 |
| New patient visit (60+ min) | 12 | $2,245 | $187 |
| Testing for presence of drug, read by direct observation | 70 | $1,148 | $13 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $464 | $20 |
2017: 5 services
| Short return visit (20+ min) | 20 | $4,210 | $66 |
| New patient visit (45+ min) | 21 | $2,856 | $136 |
| Return visit (30+ min) | 17 | $2,698 | $96 |
| Testing for presence of drug, read by direct observation | 25 | $425 | $15 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $209 | $19 |
Drugs they prescribed that Part D paid
$48,818
Pharmacies billed $48,818 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 57% of their Part D prescriptions (599 of 1,056) in 2024. Above the middle of the specialty; the typical pain management clinician is at 44%. Long-acting opioids: 19% of their opioid prescriptions.
1,033 generic and 23 brand-name prescriptions · $48,818 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Belbuca | 13 | $12,634 | $972 |
| Buprenorphine | 30 | $8,448 | $282 |
| Hydrocodone-Acetaminophen | 344 | $7,020 | $20 |
| Lidocaine | 12 | $1,748 | $146 |
| Morphine Sulfate Er | 33 | $1,691 | $51 |
See all 19 drugs
| Belbuca | 13 | $12,634 | $972 |
| Buprenorphine | 30 | $8,448 | $282 |
| Hydrocodone-Acetaminophen | 344 | $7,020 | $20 |
| Lidocaine | 12 | $1,748 | $146 |
| Morphine Sulfate Er | 33 | $1,691 | $51 |
| Fentanyl | 19 | $1,566 | $82 |
| Pregabalin | 55 | $1,263 | $23 |
| Diclofenac | 30 | $1,041 | $35 |
| Gabapentin | 91 | $889 | $10 |
| Oxycodone | 49 | $620 | $13 |
| Oxycodone-Acetaminophen | 26 | $491 | $19 |
| Celecoxib | 29 | $403 | $14 |
| Baclofen | 40 | $344 | $9 |
| Cyclobenzaprine | 57 | $306 | $5 |
| Tramadol | 57 | $242 | $4 |
| Methadone | 13 | $214 | $16 |
| Tizanidine | 35 | $200 | $6 |
| Duloxetine | 17 | $176 | $10 |
| Meloxicam | 26 | $52 | $2 |
Year by year
| 2024 | 1,056 | 125 | 57% (599) | 2% | $48,818 |
| 2023 | 1,466 | 159 | 51% (754) | 3% | $86,605 |
| 2022 | 2,253 | 169 | 56% (1,262) | 5% | $131,846 |
| 2021 | 2,351 | 155 | 52% (1,229) | 5% | $112,999 |
| 2020 | 2,510 | 170 | 54% (1,362) | 7% | $154,395 |
| 2019 | 2,258 | 179 | 55% (1,249) | 14% | $202,200 |
| 2018 | 1,652 | 160 | 56% (923) | 16% | $165,551 |
| 2017 | 854 | 118 | 57% (485) | 18% | $60,718 |
| 2016 | 250 | 86 | 46% (114) | 12% | $23,425 |
| 2015 | 205 | 72 | 50% (103) | 15% | $22,113 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Buprenorphine | 32 | $12,414 | $388 |
| Hydrocodone-Acetaminophen | 399 | $10,927 | $27 |
| Pregabalin | 91 | $4,027 | $44 |
| Diclofenac | 101 | $3,927 | $39 |
| Gabapentin | 117 | $2,552 | $22 |
| Celecoxib | 40 | $1,824 | $46 |
| Cyclobenzaprine | 69 | $1,255 | $18 |
| Naloxone | 14 | $1,233 | $88 |
| Morphine Sulfate Er | 27 | $1,143 | $42 |
| Tizanidine | 71 | $1,135 | $16 |
| Oxycodone-Acetaminophen | 58 | $1,117 | $19 |
| Fentanyl | 19 | $1,076 | $57 |
| Oxycodone | 60 | $1,034 | $17 |
| Baclofen | 49 | $998 | $20 |
| Duloxetine | 17 | $955 | $56 |
| Acetaminophen-Codeine | 27 | $748 | $28 |
| Methadone | 36 | $656 | $18 |
| Tramadol | 70 | $644 | $9 |
| Meloxicam | 33 | $443 | $13 |
| Carisoprodol | 14 | $204 | $15 |
| Methocarbamol | 12 | $178 | $15 |
2022: 24 drugs
| Buprenorphine | 57 | $20,407 | $358 |
| Hydrocodone-Acetaminophen | 619 | $18,058 | $29 |
| Hysingla Er | 17 | $11,262 | $662 |
| Gabapentin | 209 | $5,619 | $27 |
| Pregabalin | 114 | $5,590 | $49 |
| Fentanyl | 37 | $4,150 | $112 |
| Diclofenac | 121 | $4,080 | $34 |
| Oxycodone-Acetaminophen | 114 | $2,280 | $20 |
| Cyclobenzaprine | 85 | $2,176 | $26 |
| Oxycodone | 84 | $1,943 | $23 |
| Tizanidine | 144 | $1,604 | $11 |
| Methadone | 83 | $1,573 | $19 |
| Baclofen | 64 | $1,088 | $17 |
| Morphine Sulfate Er | 41 | $1,003 | $24 |
| Acetaminophen-Codeine | 43 | $957 | $22 |
| Morphine Sulfate | 15 | $937 | $62 |
| Tramadol | 106 | $812 | $8 |
| Duloxetine | 20 | $690 | $34 |
| Carisoprodol | 32 | $563 | $18 |
| Topiramate | 14 | $349 | $25 |
| Meloxicam | 54 | $206 | $4 |
| Nabumetone | 13 | $201 | $15 |
| Nortriptyline | 15 | $146 | $10 |
| Ibuprofen | 23 | $78 | $3 |
2021: 30 drugs
| Buprenorphine | 57 | $20,279 | $356 |
| Nucynta Er | 11 | $17,441 | $1,586 |
| Hydrocodone-Acetaminophen | 581 | $15,118 | $26 |
| Pregabalin | 126 | $6,377 | $51 |
| Hysingla Er | 11 | $6,368 | $579 |
| Gabapentin | 216 | $5,357 | $25 |
| Movantik | 14 | $5,273 | $377 |
| Lidocaine | 25 | $4,292 | $172 |
| Diclofenac | 161 | $4,185 | $26 |
| Fentanyl | 32 | $4,183 | $131 |
| Oxycodone-Acetaminophen | 136 | $3,663 | $27 |
| Methadone | 119 | $2,383 | $20 |
| Tizanidine | 145 | $2,033 | $14 |
| Xtampza Er | 11 | $1,728 | $157 |
| Cyclobenzaprine | 90 | $1,717 | $19 |
| Duloxetine | 41 | $1,600 | $39 |
| Oxycodone | 76 | $1,432 | $19 |
| Morphine Sulfate Er | 37 | $1,293 | $35 |
| Baclofen | 55 | $1,283 | $23 |
| Morphine Sulfate | 18 | $926 | $51 |
| Acetaminophen-Codeine | 31 | $771 | $25 |
| Carisoprodol | 26 | $480 | $18 |
| Topiramate | 17 | $355 | $21 |
| Tramadol | 96 | $337 | $4 |
| Nabumetone | 15 | $259 | $17 |
| Ibuprofen | 29 | $228 | $8 |
| Meloxicam | 81 | $215 | $3 |
| Mirtazapine | 15 | $153 | $10 |
| Diazepam | 12 | $83 | $7 |
| Hydromorphone | 11 | $80 | $7 |
2020: 32 drugs
| Oxycontin | 13 | $32,858 | $2,528 |
| Buprenorphine | 66 | $23,046 | $349 |
| Nucynta Er | 11 | $13,269 | $1,206 |
| Hydrocodone-Acetaminophen | 622 | $13,252 | $21 |
| Hysingla Er | 14 | $7,575 | $541 |
| Diclofenac | 171 | $4,923 | $29 |
| Tizanidine | 181 | $4,898 | $27 |
| Pregabalin | 78 | $4,498 | $58 |
| Movantik | 12 | $4,480 | $373 |
| Fentanyl | 40 | $4,094 | $102 |
| Oxycodone-Acetaminophen | 142 | $4,093 | $29 |
| Gabapentin | 206 | $3,656 | $18 |
| Methadone | 168 | $2,770 | $16 |
| Oxycodone | 92 | $2,362 | $26 |
| Morphine Sulfate Er | 36 | $2,226 | $62 |
| Duloxetine | 49 | $1,901 | $39 |
| Cyclobenzaprine | 89 | $1,280 | $14 |
| Morphine Sulfate | 23 | $1,139 | $50 |
| Doxepin | 22 | $1,006 | $46 |
| Acetaminophen-Codeine | 33 | $962 | $29 |
| Lidocaine | 11 | $782 | $71 |
| Tramadol | 86 | $567 | $7 |
| Baclofen | 51 | $563 | $11 |
| Topiramate | 39 | $488 | $13 |
| Carisoprodol | 27 | $342 | $13 |
| Mirtazapine | 15 | $337 | $22 |
| Meloxicam | 56 | $243 | $4 |
| Ibuprofen | 32 | $221 | $7 |
| Nabumetone | 12 | $194 | $16 |
| Nortriptyline | 17 | $130 | $8 |
| Pantoprazole | 11 | $96 | $9 |
| Diazepam | 15 | $39 | $3 |
2019: 31 drugs
| Oxycontin | 19 | $36,011 | $1,895 |
| Lyrica | 67 | $35,145 | $525 |
| Buprenorphine | 70 | $24,558 | $351 |
| Butrans | 31 | $19,243 | $621 |
| Hydrocodone-Acetaminophen | 533 | $12,642 | $24 |
| Hysingla Er | 15 | $9,454 | $630 |
| Morphine Sulfate Er | 35 | $4,654 | $133 |
| Fentanyl | 49 | $4,631 | $95 |
| Oxycodone-Acetaminophen | 116 | $3,835 | $33 |
| Gabapentin | 168 | $3,731 | $22 |
| Movantik | 11 | $3,695 | $336 |
| Tizanidine | 142 | $3,660 | $26 |
| Duloxetine | 70 | $2,959 | $42 |
| Methadone | 164 | $2,712 | $17 |
| Pregabalin | 32 | $2,621 | $82 |
| Diclofenac | 61 | $2,345 | $38 |
| Voltaren | 30 | $1,977 | $66 |
| Oxycodone | 93 | $1,829 | $20 |
| Celecoxib | 17 | $1,184 | $70 |
| Morphine Sulfate | 13 | $846 | $65 |
| Topiramate | 58 | $832 | $14 |
| Oxycodone Hcl-Aspirin | 11 | $808 | $73 |
| Doxepin | 16 | $745 | $47 |
| Baclofen | 51 | $668 | $13 |
| Cyclobenzaprine | 54 | $596 | $11 |
| Tramadol | 59 | $387 | $7 |
| Acetaminophen-Codeine | 24 | $372 | $16 |
| Meloxicam | 54 | $319 | $6 |
| Mirtazapine | 17 | $256 | $15 |
| Ibuprofen | 27 | $234 | $9 |
| Nortriptyline | 17 | $142 | $8 |
2018: 30 drugs
| Lyrica | 59 | $35,892 | $608 |
| Oxycontin | 18 | $33,843 | $1,880 |
| Butrans | 25 | $15,018 | $601 |
| Buprenorphine | 37 | $13,614 | $368 |
| Hydrocodone-Acetaminophen | 382 | $10,759 | $28 |
| Fentanyl | 54 | $4,819 | $89 |
| Morphine Sulfate Er | 36 | $3,920 | $109 |
| Gabapentin | 125 | $3,514 | $28 |
| Lidocaine | 11 | $2,230 | $203 |
| Duloxetine | 53 | $1,975 | $37 |
| Oxycodone-Acetaminophen | 65 | $1,916 | $29 |
| Methadone | 103 | $1,740 | $17 |
| Oxycodone | 68 | $1,739 | $26 |
| Voltaren | 28 | $1,596 | $57 |
| Morphine Sulfate | 27 | $1,252 | $46 |
| Tizanidine | 78 | $1,240 | $16 |
| Cyclobenzaprine | 40 | $1,208 | $30 |
| Doxepin | 24 | $1,129 | $47 |
| Diclofenac | 24 | $709 | $30 |
| Acetaminophen-Codeine | 24 | $639 | $27 |
| Topiramate | 42 | $544 | $13 |
| Baclofen | 35 | $532 | $15 |
| Nortriptyline | 31 | $482 | $16 |
| Hydromorphone | 16 | $263 | $16 |
| Meloxicam | 43 | $258 | $6 |
| Sumatriptan | 12 | $229 | $19 |
| Carisoprodol | 22 | $189 | $9 |
| Tramadol | 30 | $148 | $5 |
| Ibuprofen | 13 | $103 | $8 |
| Diazepam | 15 | $39 | $3 |
2017: 19 drugs
| Fentanyl | 50 | $4,721 | $94 |
| Hydrocodone-Acetaminophen | 190 | $4,398 | $23 |
| Methadone | 82 | $1,911 | $23 |
| Gabapentin | 64 | $1,681 | $26 |
| Morphine Sulfate Er | 19 | $1,387 | $73 |
| Duloxetine | 19 | $1,208 | $64 |
| Tizanidine | 42 | $899 | $21 |
| Voltaren | 14 | $732 | $52 |
| Oxycodone-Acetaminophen | 24 | $551 | $23 |
| Doxepin | 12 | $533 | $44 |
| Morphine Sulfate | 13 | $529 | $41 |
| Oxycodone | 16 | $438 | $27 |
| Nortriptyline | 23 | $425 | $18 |
| Topiramate | 27 | $315 | $12 |
| Acetaminophen-Codeine | 14 | $293 | $21 |
| Cyclobenzaprine | 23 | $216 | $9 |
| Baclofen | 23 | $211 | $9 |
| Tramadol | 24 | $101 | $4 |
| Meloxicam | 21 | $77 | $4 |
2016: 7 drugs
| Lyrica | 11 | $5,492 | $499 |
| Morphine Sulfate Er | 17 | $1,646 | $97 |
| Hydrocodone-Acetaminophen | 39 | $1,322 | $34 |
| Tizanidine | 22 | $700 | $32 |
| Oxycodone | 15 | $695 | $46 |
| Gabapentin | 23 | $519 | $23 |
| Cephalexin | 18 | $203 | $11 |
2015: 3 drugs
| Oxycodone-Acetaminophen | 16 | $1,742 | $109 |
| Hydrocodone-Acetaminophen | 24 | $859 | $36 |
| Gabapentin | 11 | $159 | $14 |
Money from drug and device companies
$20 in 2024
| 2024 | 1 | 1 | None | $20 |
| 2020 | 4 | 4 | None | $60 |
| 2019 | 9 | 12 | None | $209 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Nalu Medical | Nalu Neurostimulation System | $20 | 1 payment
|
See the published payment
| Nalu Medical | Meals · 2024-07-18 | Nalu Neurostimulation System | $20 |
See earlier years (2020, 2019)
2020: $60
| Pfizer | Flector | $17 | 1 payment
|
| Teva Pharmaceuticals USA | Ajovy | $16 | 1 payment
|
| Collegium Pharmaceutical | Xtampza | $15 | 1 payment
|
| Sanofi-Aventis U.S. | Synvisc-One | $11 | 1 payment
|
2019: $209
| Scilex Pharmaceuticals | Ztlido 30 Pouch in 1 Carton 1 Patch in 1 Pouch | $48 | 3 payments
|
| Medtronic USA | Mystim | $47 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $24 | 1 payment
|
| Pfizer | Lyrica | $24 | 2 payments
|
| Assertio Therapeutics | Gralise | $16 | 1 payment
|
| Arbor Pharmaceuticals | Horizant | $14 | 1 payment
|
| Teva Pharmaceuticals USA | Ajovy | $13 | 1 payment
|
| BioDelivery Sciences International | Bunavail 2.1 Mg 30-Count Box | $12 | 1 payment
|
| Collegium Pharmaceutical | Xtampza | $12 | 1 payment
|
Professional record
- NPI
- 1093000226
- Licence
- CA A144608California A144608: Current · expires 2027-10-31
- Trained
- Rush Medical College of Rush University, 2011 · 15 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X)
- Mailing address
- 1335 Stanford Ave, Emeryville, CA, 94608
- NPI first listed
- 2011-06-16
- NPI last updated
- 2016-11-03
This is when the NPI record was last certified, not a medical board exam.